IRIS
DI SERAFINO, LUIGI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.969
NA - Nord America 2.749
EU - Europa 2.512
SA - Sud America 490
AF - Africa 108
OC - Oceania 6
Totale 9.834
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.646
SG - Singapore 1.759
RU - Federazione Russa 1.202
CN - Cina 784
VN - Vietnam 726
IT - Italia 474
BR - Brasile 380
HK - Hong Kong 303
FR - Francia 155
NL - Olanda 153
DE - Germania 145
FI - Finlandia 109
BD - Bangladesh 80
GB - Regno Unito 65
JP - Giappone 65
CA - Canada 62
UA - Ucraina 55
AR - Argentina 46
IE - Irlanda 36
KR - Corea 36
IN - India 33
CI - Costa d'Avorio 27
ZA - Sudafrica 25
MX - Messico 23
TH - Thailandia 23
ID - Indonesia 21
IQ - Iraq 19
PH - Filippine 18
AT - Austria 17
EC - Ecuador 17
PL - Polonia 17
TW - Taiwan 16
SE - Svezia 15
PK - Pakistan 14
ES - Italia 13
VE - Venezuela 11
CH - Svizzera 10
CL - Cile 9
CZ - Repubblica Ceca 9
TR - Turchia 9
CO - Colombia 8
KE - Kenya 8
MA - Marocco 8
LT - Lituania 7
MY - Malesia 7
PY - Paraguay 7
AE - Emirati Arabi Uniti 6
EG - Egitto 6
IL - Israele 6
SA - Arabia Saudita 6
TN - Tunisia 6
UY - Uruguay 6
UZ - Uzbekistan 6
BG - Bulgaria 5
DZ - Algeria 5
ET - Etiopia 5
IR - Iran 5
OM - Oman 5
BE - Belgio 4
JM - Giamaica 4
JO - Giordania 4
AL - Albania 3
DO - Repubblica Dominicana 3
KZ - Kazakistan 3
NZ - Nuova Zelanda 3
PE - Perù 3
RO - Romania 3
AZ - Azerbaigian 2
BN - Brunei Darussalam 2
BO - Bolivia 2
GT - Guatemala 2
KG - Kirghizistan 2
LB - Libano 2
LV - Lettonia 2
ME - Montenegro 2
MK - Macedonia 2
MW - Malawi 2
NP - Nepal 2
PA - Panama 2
PT - Portogallo 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
YT - Mayotte 2
AO - Angola 1
AU - Australia 1
BB - Barbados 1
BJ - Benin 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CM - Camerun 1
CR - Costa Rica 1
EE - Estonia 1
GA - Gabon 1
GF - Guiana Francese 1
GH - Ghana 1
GN - Guinea 1
HU - Ungheria 1
KH - Cambogia 1
Totale 9.818
Salva come PNG Salva come JPEG
Città #
Singapore 848
San Jose 491
Moscow 304
Hong Kong 289
Ashburn 249
Ho Chi Minh City 204
Beijing 185
Hanoi 175
Hefei 156
Naples 153
Chandler 143
Amsterdam 133
Santa Clara 105
Los Angeles 93
Lauterbourg 89
The Dalles 88
Millbury 78
Boston 68
Princeton 64
Nanjing 58
Tokyo 57
New York 54
Munich 53
Buffalo 42
Redondo Beach 39
Des Moines 35
Haiphong 35
Da Nang 30
Ottawa 29
Seoul 29
São Paulo 28
Frankfurt am Main 27
Orem 26
Dallas 24
Jacksonville 24
Wilmington 24
Council Bluffs 23
Lappeenranta 19
Afragola 18
Nanchang 18
Rome 18
Nuremberg 17
Rio de Janeiro 17
Turku 17
Denver 16
Helsinki 16
Biên Hòa 15
Lawrence 15
Shenyang 15
Tianjin 14
Atlanta 13
Jiaxing 13
Milan 13
Seattle 13
Bangkok 12
Boardman 12
Dong Ket 12
Johannesburg 12
Poplar 12
Warsaw 12
Baghdad 11
Belo Horizonte 11
Chicago 11
Hebei 11
Napoli 11
Stockholm 11
Washington 11
Brasília 10
Chennai 10
Montreal 10
Phoenix 10
San Francisco 10
Brooklyn 9
Can Tho 9
Porto Alegre 9
Augusta 8
City of London 8
Dhaka 8
Lahore 8
Montecchio Emilia 8
Nairobi 8
San Giuseppe Vesuviano 8
Shanghai 8
Thái Nguyên 8
Toronto 8
Buenos Aires 7
Caracas 7
Fairfield 7
Guangzhou 7
Houston 7
Norwalk 7
Ribeirão Preto 7
Roubaix 7
Torre del Greco 7
Guarulhos 6
Guayaquil 6
Hải Dương 6
London 6
Montevideo 6
Paris 6
Totale 5.224
Salva come PNG Salva come JPEG
Nome #
True double bifurcation lesions: new application of the self-expandable Axxess stent and review of literature with dedicated bifurcation devices 174
LA TRANSATTIVAZIONE Gβγ-DIPENDENTE DEL RECETTORE DELL’EGF E’ MEDIATA DAL RECETTORE DELL’UROTENSINA II 165
Ticagrelor 60 vs. 90 mg in elderly ACS patients undergoing PCI: a randomized, crossover trial 152
Contemporary Evidence and Practice on Right Heart Catheterization in Patients with Acute or Chronic Heart Failure 147
Effects of Successful Percutaneous Lower Extremity Revascularization on Cardiovascular Outcome in Patients with Peripheral Arterial Disease 146
Pharmacodynamic effects of cangrelor in elective complex PCI: insights from the POMPEII Registry 142
ADDED Index or percentage diameter of residual coronary stenosis to risk-stratify patients presenting with STEMI 140
A Comparison Between Radial Artery Compression Devices for Patent Hemostasis After Transradial Percutaneous Interventions 139
Predictors of adherence to composite therapy after acute coronary syndromes 138
Extent of cardiac damage and mortality in patients undergoing transcatheter aortic valve implantation 137
Low-dose quinacrine reduces vascular restenosis without affecting re-endothelialization 136
L’IMPIANTO DI STENT NELLE ARTERIE DEGLI ARTI INFERIORI RIDUCE IL RISCHIO CARDIOVASCOLARE IN PAZIENTI CON ATEROSCLEROSI PLURIDISTRETTUALE. 135
Periprocedural myocardial infarction in patients undergoing complex versus noncomplex percutaneous coronary intervention 134
Polymer-free versus biodegradable-polymer drug-eluting stent in patients undergoing percutaneous coronary intervention: an assessor-blind, non-inferiority, randomised controlled trial 134
Impact of COVID-19 pandemic on timing and early clinical outcomes of transcatheter aortic valve implantation 130
Quinacrine as a Novel Anti-Restenotic and Anti-Thrombotic Drug for Coronary Artery Interventions. 128
Prevenzione della restenosi e della trombosi intrastent: ruolo del derivato acridinico quinacrina 127
Induction of mitogen activated protein kinases in response to pressure overload: a novel possible biomarker for uncontrolled human hypertension. 126
Myocardial mass affects diagnostic performance of non-hyperemic pressure-derived indexes in the assessment of coronary stenosis 123
ATHERECTOMY AS ALTERNATIVE ENDOVASCULAR THERAPY FOR INFRAINGUINAL ARTERY DISEASE. 123
Effects of Guiding Catheter Disengagement on Resting Indexes for the Assessment of Coronary Artery Stenoses 122
Ruolo dell’ UII nello sviluppo dell’ipertrofia cardiaca in vivo e nella transizione verso lo scompenso cardiaco congestizio 122
Management of Non-Culprit Lesions in STEMI Patients with Multivessel Disease 121
Quinacrine as a novel drug in the prevention of in-stent restenosis and thrombosis. 121
Clopidogrel versus ticagrelor in high-bleeding risk patients presenting with acute coronary syndromes: insights from the multicenter START-ANTIPLATELET registry 119
Functionally complete coronary revascularisation in patients presenting with ST-elevation MI and multivessel coronary artery disease 119
Rotational atherectomy for the treatment of isolated femoral artery traumatic lesion: A case report 117
Gβγ-dependent transactivation of the epidermal growth factor receptor by the Urotensin-II receptor. 116
Ruolo del derivato acridinico Quinacrina nella prevenzione della restenosi e della trombosi intrastent. 116
Vantaggi del trattamento endoprotesico degli aneurismi aortici in categorie ad alto rischio chirurgico. 116
Cangrelor in contemporary patients with ST-segment elevation myocardial infarction pretreated with Ticagrelor: Pharmacodynamic data from the POMPEII study 115
Very late bioresorbable scaffold thrombosis and reoccurrence of dissection two years later chronic total occlusion recanalization of the left anterior descending artery 115
Platelet Inhibition with Ticagrelor 60 mg Versus 90 mg Twice Daily in Elderly Patients with Acute Coronary Syndrome: Rationale and Design of the PLINY THE ELDER Trial 115
Platelet reactivity and coronary microvascular impairment after percutaneous revascularization in stable patients receiving clopidogrel or prasugrel 113
L’ipertrofia miocardia da sovraccarico pressorio induce un notevole incremento dell’espressione di C-Flip, una proteina indispensabile per lo sviluppo embrionale del cuore 112
L’Urotensina II svolge un ruolo protettivo nel rimodellamento post-ischemico e nella transizione verso lo scompenso cardiaco congestizio 111
Coronary microcirculation and peri-procedural myocardial injury during elective percutaneous coronary intervention 109
AngioJet rheolytic thrombectomy for acute superficial femoral artery stent or femoropopliteal by-pass thrombosis 108
Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes: Insights from the START-ANTIPLATELET registry 107
L’urotensina II svolge un ruolo protettivo nel rimodellamento post ischemico e nella transizione verso lo scompenso cardiaco congestizio 106
Vantaggi del trattamento endoprotesico degli aneurismi aortici in categorie ad alto rischio chirurgico 106
Effetti dell’Urotensina II sulle proliferazione delle fibrocellule muscolari lisce 105
Effects of colchicine on platelet aggregation in patients on dual antiplatelet therapy with aspirin and clopidogrel 105
Uric acid plasma levels are associated with C-reactive protein concentrations and the extent of coronary artery lesions in patients with acute coronary syndromes 104
Ruolo dell’UII nello sviluppo dell’ipertrofia cardiaca in vivo e nella transizione verso lo scompenso cardiaco congestizio. 104
Il ruolo dell’Urotensina II nel rimodellamento post-ischemico e nella transizione verso lo scompenso cardiaco congestizio 104
Ruolo dell’urotensina II (UII) nello sviluppo dell’ipertrofia cardiaca in vivo e nella transizione verso lo scompenso cardiaco congestizio 102
Invasive Assessment of Coronary Microcirculation: A State-of-the-Art Review 101
Ruolo dell’Urotensina II nello sviluppo dell’ipertrofia cardiaca in vivo e nella transizione verso lo scompenso cardiaco congestizio 99
Histamine release, after peripheral ischemia, induce inteleukin 16 (II-16) expression and regulate collateral vessel development in mice. 99
Impact of biomarker type on periprocedural myocardial infarction in patients undergoing elective PCI 98
La ridotta risposta ipertrofica da sovraccarico pressorio si associa a dilatazione ventricolare sinistra e ridotto reclutamento di cellule T CD4+ CD8+ in un modello murino di diabete mellito tipo II 97
ACEF and clinical SYNTAX score in the risk stratification of patients with heavily calcified coronary stenosis undergoing rotational atherectomy with stent implantation. 97
Double-kissing culotte technique for coronary bifurcation stenting 97
La ridotta risposta ipertrofica da sovraccarico pressorio si associa a dilatazione ventricolare sinistra e ridotto reclutamento di cellule T CD4+ CD8+ in un modello murino di diabete mellito tipo II 96
Pharmacodynamic effects of cangrelor in patients with acute or chronic coronary syndrome undergoing percutaneous coronary intervention: the POMPEII Registry 95
FFR prediction model based on conventional quantitative coronary angiography and the amount of myocardium subtended by an intermediate coronary artery stenosis 91
Evolving concepts of angiogram: fractional flow reserve discordances in 4000 coronary stenoses. 89
The role of fractional flow reserve to guide stent implantation. 85
Monocyte-platelets aggregates as cellular biomarker of endothelium-dependent coronary vasomotor dysfunction in patients with coronary artery disease. 83
Influence of transradial versus transfemoral diagnostic heart catheterisation on peripheral vascular endothelial function. 83
Artificial Intelligence as a Tool for Diagnosis of Cardiac Amyloidosis: A Systematic Review 82
Endovascular repair for isolated iliac artery aneurysms: case report and review of the current literature. 82
Long-term clinical outcome after fractional flow reserve- versus angio-guided percutaneous coronary intervention in patients with intermediate stenosis of coronary artery bypass grafts. 81
Macrophage migration inhibitory factor (MIF) is associated with degree of collateralization in patients with totally occluded coronary arteries 80
The age, creatinine, and ejection fraction score to risk stratify patients who underwent percutaneous coronary intervention of coronary chronic total occlusion. 79
Comparison of the Effect of Dual-Axis Rotational Coronary Angiography Versus Conventional Coronary Angiography on Frequency of Acute Kidney Injury, X-Ray Exposure Time, and Quantity of Contrast Medium Injected 79
Revascularization Decisions in Patients With Stable Angina and Intermediate Lesions: Results of the International Survey on Interventional Strategy. 78
Effects of Prasugrel Versus Clopidogrel on Coronary Microvascular Function in Patients Undergoing Elective PCI 75
Fractional flow reserve-guided versus angiography-guided coronary artery bypass graft surgery. 72
Impact of negative lesion characteristics of chronic total occlusions on procedural outcome and strategy. 71
Pathophysiology and mechanisms of Acute Coronary Syndromes: atherothrombosis, immune-inflammation, and beyond 70
ACEF vs PARIS score in Predicting Cardiovascular Events in Patients With Acute Coronary Syndrome: Insights From the START ANTIPLATELET Registry 70
Response to letter regarding article, "revascularization decisions in patients with stable angina and intermediate lesions: Results of the international survey on interventional strategy" 70
Diagnostic performance of in-procedure angiography-derived quantitative flow reserve compared to pressure-derived fractional flow reserve: The FAVOR II Europe-Japan study 70
Impact of alpha- and Beta-adrenergic receptor blockers on fractional flow reserve and index of microvascular resistance. 67
[Ischemia with non-obstructive coronary artery disease: state-of-the-art review] 65
C-flip, A protein Required For Embryonic Heart Development, is markedly increased in pressure overload myocardial hypertrophy 65
Quantitative angiography and optical coherence tomography for the functional assessment of nonobstructive coronary stenoses: comparison with fractional flow reserve. 64
Intracoronary EnalaPrilat to Reduce MICROvascular Damage During Percutaneous Coronary Intervention (ProMicro) study. 64
Stent implantation in the arteries of the lower limbs reduces cardiovascular risk in peripheral arterial disease. 63
Effects of urotensin II inhibition on smooth muscle cell proliferation and apoptosis 62
SAFETY AND EFFICACY OF OUBACK CATHETER-ASSISTED SUBINTIMAL RECANALIZATION OF TOTAL CHRONIC ILIAC ARTERY OCCLUSION. 62
Gender-Related Differences in Antiplatelet Therapy and Impact on 1-Year Clinical Outcome in Patients Presenting With ACS: The START ANTIPLATELET Registry 62
Personalized or Standard Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention 61
Impact of dual antiplatelet therapy duration on clinical outcome after coronary bifurcation stenting: results from the EuroBifurcation Club registry 61
Antiplatelet therapy in acute coronary syndromes. Lights and shadows of platelet function tests to guide the best therapeutic approach 61
Prognostic value of fractional?flow?reserve: linking physiologic severity to clinical outcomes. 61
How would I treat? The invited expert's opinion 61
Contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention without acute left ventricular ejection fraction impairment. 58
May FFR-guided PCI save lives?: Commentary on: “Clinical impact of FFR-guided PCI compared to angio-guided PCI from the France PCI registry” 57
RUOLO DEL DERIVATO ACRIDINICO QUINACRINA NELLA PREVENZIONE DELLA RESTENOSI E DELLA TROMBOSI INTRASTENT. 57
Effect of Body Mass Index on Ischemic and Bleeding Events in Patients Presenting With Acute Coronary Syndromes (from the START-ANTIPLATELET Registry) 57
Incidence and Prognostic Impact of New-Onset Ischemic Symptoms Following Elective Percutaneous Coronary Intervention in Chronic Coronary Syndromes 56
In-stent fractional flow reserve variations and related optical coherence tomography findings: the FFR-OCT co-registration study 55
Periprocedural Myocardial Injury and Long-Term Clinical Outcome in Patients Undergoing Percutaneous Coronary Interventions of Coronary Chronic Total Occlusion 52
Invasive functional assessment of coronary artery stenosis using fractional flow reserve 51
Periprocedural variations of platelet reactivity during elective percutaneous coronary intervention. 51
Ischaemic and bleeding events after complex versus non-complex PCI: a systematic review and meta-analysis 50
Transfemoral PTA of total subclavian occlusion anatomic definition prior stent implantation by Amicath rapid exchange catheter 50
Totale 9.648
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.163
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.163
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202132 0 0 0 0 0 0 0 0 0 0 19 13
2021/2022361 1 3 3 2 1 17 4 17 48 14 57 194
2022/2023511 80 32 23 14 58 36 7 31 65 124 24 17
2023/2024539 23 85 94 52 23 43 13 37 20 15 82 52
2024/20252.725 138 114 14 43 71 101 342 182 205 278 1.014 223
2025/20265.336 574 442 564 506 867 216 585 317 674 377 214 0
Totale 9.979